← Back to Search

Cell Therapy

All Participants (within patient control) for Vitiligo

N/A
Waitlist Available
Research Sponsored by Avita Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 24
Awards & highlights

Study Summary

This trial will test a new spray-on skin cell treatment for people with vitiligo, a condition that causes patches of skin to lose color.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of ≥80% Study Area Repigmentation
Secondary outcome measures
Color Matching
Repigmentation Category

Trial Design

1Treatment groups
Experimental Treatment
Group I: All Participants (within patient control)Experimental Treatment2 Interventions
Each participant will serve as their own Control, receiving both Control and Investigational Interventions randomly allocated to treatment of a portion of a depigmented vitiligo lesion.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Control Intervention (UVB)
2020
N/A
~30
Investigational Interventions (Ablative Laser Resurfacing + RECELL + UVB)
2020
N/A
~30

Find a Location

Who is running the clinical trial?

Avita MedicalLead Sponsor
15 Previous Clinical Trials
625 Total Patients Enrolled
4 Trials studying Vitiligo
141 Patients Enrolled for Vitiligo

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available to volunteers of this experiment?

"Clinicaltrials.gov reports that this medical investigation is not accepting applications for participation at present, even though it was posted on September 10th and last updated November 16th of 2020. Fortunately, there are 37 additional clinical trials seeking participants across the United States currently."

Answered by AI

How many healthcare facilities are currently implementing this trial?

"The list of 16 trial sites consists of University of California, Davis in Sacramento, Skin care Research, LLC in Hollywood and University of Massachusetts in Worcester; the remaining spots are spread across various other cities."

Answered by AI

Who else is applying?

What state do they live in?
California
Georgia
Other
Texas
How old are they?
65+
18 - 65
What site did they apply to?
West Dermatology
Medical University of South Carolina
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria

How responsive is this trial?

Most responsive sites:
  1. West Dermatology: < 48 hours
Typically responds via
Phone Call
Average response time
  • < 2 Days
Recent research and studies
clinicaltrials.govStudy
Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions
2020. "Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04547998.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top